BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

FDA Delays Abbott Laboratories (ABT)'s New Use for Top Drug Humira


5/23/2012 7:36:45 AM

Abbott Laboratories (ABT) (ABT)’ bid to expand use of its best-selling arthritis treatment Humira to ulcerative colitis patients is being delayed by U.S. regulators. “We did receive a complete response letter several months ago and have provided additional information to the” Food and Drug Administration, Elizabeth Hoff, a spokeswoman for the Abbott Park, Illinois-based company, said in an e-mail today. “We’re anticipating a decision by the end of the year.” Ulcerative colitis is an inflammation of the large intestine and rectum caused by unknown immune system problems, according to the National Institutes of Health’s website. The condition can lead to abdominal pain, diarrhea, bloody stool and weight loss. About 500,000 people in the U.S. have the disease, according to the Crohn’s & Colitis Foundation of America.

Read at BusinessWeek
Read at Market Watch
Read at Nasdaq
Read at News Release

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES